ALPHA TRIBE

Eris Lifesciences LimitedBoard Meeting, 12-11-2025: Outcome of Board Meeting

12-11-2025 | 01:46 pm

Eris Lifesciences board cleared Q2/H1 FY26 consolidated financials: Q2 Net Profit Rs 134.47 Cr, H1 Net Profit Rs 259.57 Cr. Directors Krishnakumar Vaidyanathan (WTD) & Kalpana Unadkat (ID) proposed for re-appointment for 5-year terms, pending shareholder vote.

No comments yet. Be the first to comment!

All announcements from Eris Lifesciences Limited